Potential coronavirus drugs may cost as little as $1, study says

Bloomberg

10 April 2020 - Treatments being studied sell for hundreds of times their cost.

Potential coronavirus treatments could be made for as little as $1, well below their typical price tags in pharmacies, according to an analysis of nine drugs in clinical trials.

If their promise is confirmed in ongoing studies, medicines for COVID-19, including hydroxychloroquine, which President Donald Trump touted as a treatment, and Gilead Sciences Inc.’s remdesivir could be manufactured from $1 to $29 a course, a study published Friday in the Journal of Virus Eradication found.

Read Bloomberg article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Pricing , COVID-19